Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Treatment and Clinical Outcomes Among SLE Patients in Pregnancy — Stella

Home/Systemic Lupus Erythematosus/Treatment and Clinical Outcomes Among SLE Patients in Pregnancy

View on ClinicalTrials.gov

Recruiting

Back to Systemic Lupus Erythematosus trials

Treatment and Clinical Outcomes Among SLE Patients in Pregnancy

Phase 1 — Early testing in a small group of people (usually 20–80) to evaluate safety, determine safe dosage, and identify side effects.

Trial locations(1 site)

China

Qilu Hospital, Jinan, Shandong

Key details

Phase

Early testing

Sponsor

Qilu Hospital of Shandong University

Enrollment target

~200 participants

Started

January 2018

Primary completion

July 2025

This trial's estimated completion date has passed — the record may not be fully up to date.

Age range

20 Years – 45 Years

Sex

Female only

Last updated November 2023

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.